Spotlight on OHE: Understanding Value Based Pricing

Value based pricing (VBP) is increasingly common in health care systems worldwide. OHE continues to make important contributions to the debate about VBP approaches and application through its research, publications and participation in discussions. For example, Adrian Towse was invited to participate in a January conference on translation genomics—the conversion of genomic insights into clinically useful applications—where he discussed approaches to valuing genomic medicines.

Value based pricing (VBP) is increasingly common in health care systems worldwide. OHE continues to make important contributions to the debate about VBP approaches and application through its research, publications and participation in discussions.

For example, Adrian Towse was invited to participate in a January conference on translation genomics—the conversion of genomic insights into clinically useful applications—where he discussed approaches to valuing genomic medicines. The conference was sponsored by the NHS Genetics Education and Development Centre; it focused on opportunities and challenges for translational genomics from drug discovery through use in clinical practice.

Understanding the concepts, processes and implications of VBP is important for patients and their advocates. Jon Sussex participated in a two-day conference on health care systems and the role of patients’ groups that was organised by Roche and EGAN, the Patients’ Network for Medical Research and Health, which is an alliance of European patients’ groups with a special interest in genetics, genomics and biotechnology. Jon’s presentation covered the concept and role of “value” in the regulation of medicines’ prices, the range of possible elements of value, and progress to date with the development of VBP in the UK.

OHE’s work on VBP is extensive. Click here for an overview, based on our blog posts.

Also visit the OHE site on SlideShare, which includes a presentation by Jon, The Emerging Picture of “Value Based Pricing”.

For OHE’s Research Paper analysing approaches to VBP, click here. This paper has been updated and recently published in PharmacoEconomics: Sussex, J., Towse, A. and Devlin, N. (2013) Operationalising value based pricing of medicines: A taxonomy of approaches. PharmacoEconomics. 13(1), 1-10.

For further information, please contact Jon Sussex.